These findings show that inhibiting the PI3K/Akt pathway can enhance intestinal barrier integrity, restore the proper oxidant/antioxidant balance, lessen UC symptoms, and shield colitis mice from oxidative stress-induced damage. Here, AKT1 is linked to colitis.